| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |